Comparison on effects of piracetam and oxiracetam on elderly cognitive dysfunction after cerebral hemorrhage
10.7501/j.issn.1674-6376.2017.02.017
- VernacularTitle:吡拉西坦与奥拉西坦对老年脑出血后认知功能障碍的疗效比较
- Author:
Changpeng SONG
;
Chengkai WANG
- Keywords:
piracetam;
oxiracetam;
cognitive dysfunction;
cerebral hemorrhage;
MoCA;
MMSE;
ADL;
neuron-specific enolase
- From:
Drug Evaluation Research
2017;40(2):229-232
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effects of piracetam and oxiracetam on elderly cognitive dysfunction after cerebral hemorrhage.Methods Elderly patients (82 cases) with cerebral hemorrhage treated in Tongchuan People's Hospital from January 2012 to December 2015 were selected and divided into two groups according to the different treatment drugs.Two groups were treated by oxiracetam and piracetam respectively.The Montreal cognitive assessment scale (MoCA),simple mental state examination (MMSE),and daily life ability scale (ADL) score of the two groups before and after treatment were compared.The neuron-specific enolase levels and cognitive function after treatment of 1,3,and 6 months were also compared.Results After treatment,MoCA,MMSE,and ADL scores of two groups were significantly improved (P ＜ 0.05),and oxiracetam group were significantly better than piracetam group (P ＜0.05).After treatment 6 months,MoCA,MMSE,ADL effective and total effective rate of the two groups were significantly higher (P ＜0.05),and oxiracetam group were significantly better than those ofpiracetam group (P ＜ 0.05).After treatment for 1,3,and 6 months,the neuron-specific enolase levels were significantly lower than those before treatment (P ＜ 0.05),and in the treatment of 3 and 6 months,oxiracetam group were significantly lower than piracetam group (P ＜ 0.05).The incidence of adverse reactions had no significant difference.Conclusion Oxiracetam can improve the elderly cognitive dysfunction after cerebral hemorrhage,the curative effect was increased with the prolonging of the time,and can reduce the neuron-specific enolase levels,which has high clinical value.
